Eosinophilic fasciitis (Shulman syndrome), a rare entity and diagnostic challenge, as a manifestation of severe chronic graft-versus-host disease: a case report

[1] Fett N(2018)Eosinophilic fasciitis: current concepts Clin Dermatol. 36 487-497

[2] Arthur M(2014)Diagnosis and classification of eosinophilic fasciitis Autoimmun Rev. 13 379-382

[3] Pinal-Fernandez I(2012)Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients Rheumatology 51 557-561

[4] Selva-O' Callaghan A(2015)The use of an elevated aldolase in diagnosing and managing eosinophilic fasciitis Clin Rheumatol. 34 1481-1484

[5] Grau JM(2019)Decoding skin involvement in chronic graft-vs-host disease JAMADermatol. 155 777-778

[6] Lebeaux D(2009)Fascitis and myositis: an analysis of muscle related complications caused by chronic GVHD after allo-SCT. Kanto Study Group for Cell Therapy (KSGCT) Bone Marrow Transplant. 43 159-167

[7] Frances C(2015)Chronic graft-versus-host disease presenting as eosinophilic fasciitis: therapeutic challenges and an additional case J Clin Rheumatol 21 86-94

[8] Barete S(2003)In situ immunophenotype of the inflammatory infiltrate in eosinophilic fasciitis J Rheumatol 30 1811-1815

[9] Nashel J(2017)Th1- and Th17-polarized immune infiltrates in eosinophilic fasciitis—a potential marker for histopathologic distinction from morphea J Cutan Pathol. 44 548-552

[10] Steen V(2016)International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma Lancet Oncol. 17 e328-e346

[1] Fett N(2018)Eosinophilic fasciitis: current concepts Clin Dermatol. 36 487-497

[2] Arthur M(2014)Diagnosis and classification of eosinophilic fasciitis Autoimmun Rev. 13 379-382

[3] Pinal-Fernandez I(2012)Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients Rheumatology 51 557-561

[4] Selva-O' Callaghan A(2015)The use of an elevated aldolase in diagnosing and managing eosinophilic fasciitis Clin Rheumatol. 34 1481-1484

[5] Grau JM(2019)Decoding skin involvement in chronic graft-vs-host disease JAMADermatol. 155 777-778

[6] Lebeaux D(2009)Fascitis and myositis: an analysis of muscle related complications caused by chronic GVHD after allo-SCT. Kanto Study Group for Cell Therapy (KSGCT) Bone Marrow Transplant. 43 159-167

[7] Frances C(2015)Chronic graft-versus-host disease presenting as eosinophilic fasciitis: therapeutic challenges and an additional case J Clin Rheumatol 21 86-94

[8] Barete S(2003)In situ immunophenotype of the inflammatory infiltrate in eosinophilic fasciitis J Rheumatol 30 1811-1815

[9] Nashel J(2017)Th1- and Th17-polarized immune infiltrates in eosinophilic fasciitis—a potential marker for histopathologic distinction from morphea J Cutan Pathol. 44 548-552

[10] Steen V(2016)International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma Lancet Oncol. 17 e328-e346